title: HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
abstract: BACKGROUND
  - The increase in the survival following the introduction of highly active antiretroviral therapy (HAART) has seen the emergence of hepatitis C virus (HCV) infection, renal and cardiovascular diseases as important morbidity and mortality causes together with HIV.
  
  
  OBJECTIVE
  - The present study aimed to investigate the differences between HIV/hepatitis C virus coinfected and HIV-monoinfected regarding demographic and clinical aspects from a HIV/AIDS clinic in Porto Alegre, Brazil.
  
  
  METHODS
  - Review of medical records of 1,030 HIV infected individuals aged 18 years or more in an urban HIV/AIDS clinic based in Porto Alegre, Southern Brazil. Clinical and demographical Data were collected from the records of the patients attended between March 2008 and December 2012.
  
  
  RESULTS
  - The present study is a cross-sectional study among HIV-infected patients attended at a public HIV/AIDS clinic in Porto Alegre, Brazil. The prevalence of hepatitis C virus in the present study cohort was 11.8% (CI 95%: 9.9%-13.8%). Hypertension and pathological proteinuria were more common in the coinfected compared to monoinfected group. By the other hand, dyslipidemia were more common among monoinfected patients. There was no difference between the groups regarding CD4+ count or HIV-RNA. Variables significant in the univariate analysis with P<0.05 were further analyzed using a Poisson regression model with robust variance. Coinfected were likely to be older, with lower lipid levels and higher prevalence of pathological proteinuria compared to HIV-monoinfected patients. Although coinfected patients had higher prevalence of tenofovir-based regimen, there was a strong association between hepatitis C virus individuals to pathological proteinuria and dyslipidemia.
  
  
  CONCLUSIONS
  - Clinicians should recognize that coinfected and monoinfected individuals are different groups regarding the traditional and HIV-related risk factors and should be managed and screened individually in order to prevent cardiovascular and renal complications.
authors.affiliation: Serviço de Atendimento Especializado em AIDS/DSTs IAPI, Prefeitura de Porto Alegre, RS, Brasil.|Departamento de Prevenção e Controle de Infecção, Hospital Fêmina, Porto Alegre, RS, Brasil.|Pós-Graduação em Hepatologia, Universidade Federal de Ciências da Saúde de Porto Alegre, RS, Brasil.
authors.forename: Vicente Sperb
authors.initials: VS
authors.lastname: Antonello
authors.affiliation: Programa de Pós-Graduação em Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brasil.
authors.forename: Ivan Carlos Ferreira
authors.initials: IC
authors.lastname: Antonello
authors.affiliation: Programa de Graduação em Medicina e Ciências da Saúde, Faculdade de Medicina, Pontifícia Universidade Católica de Pelotas, RS, Brasil.
authors.forename: Rosana Ferrazza
authors.initials: RF
authors.lastname: Zaltron
authors.affiliation: Pós-Graduação em Hepatologia, Universidade Federal de Ciências da Saúde de Porto Alegre, RS, Brasil.|Programa de Graduação em Medicina e Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, RS, Brasil.
authors.forename: Cristiane Valle
authors.initials: CV
authors.lastname: Tovo
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000437:Alcoholism / Q000150:complications; D001938:Brazil / Q000453:epidemiology; D060085:Coinfection / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011507:Proteinuria / Q000652:urine; D017678:Sex Distribution; D014029:Tobacco Use Disorder / Q000150:complications; D055815:Young Adult